Author

Brian Ngo

Institutions: Northern Health, Austin Hospital, Northern Hospital, Austin Health

Observed institutions: The University of Melbourne, Northern Health, Austin Hospital, Northern Hospital, NeoGenomics (United States), Austin Health

ORCID: 0000-0002-7670-8051

Observed ORCID: 0000-0002-7670-8051

OpenAlex ID: A5103752669

Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis

2018 · Jack Crozier, Nathan Papa, et al. · World Journal of Urology · 77

Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review

2017 · Brian Ngo, Marlon Perera, et al. · British Journal of Urology · 32

Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria

2017 · Brian Ngo, Nathan Papa, et al. · British Journal of Urology · 20

Outcome and safety of targeted liver biopsies for indeterminate lesions in patients with chronic liver disease: A single centre experience

2019 · Xiao Chen, Numan Kutaiba, et al. · Journal of Medical Imaging and Radiation Oncology · 10

Pulmonary artery pseudoaneurysm secondary to metastatic breast cancer

2018 · Pey Ling Shum, Brian Ngo, et al. · South Asian Journal of Cancer · 6

Imaging of Adrenal Incidentalomas: What Actually Happens in Everyday Clinical Practice?

2025 · Brian Ngo, Tracy Liu, et al. · Journal of Medical Imaging and Radiation Oncology · 5

Bladder cancer diagnosis during haematuria investigation – implications for practice guidelines

2017 · Brian Ngo, Nathan Papa, et al. · British Journal of Urology · 3

Abstract 4041: Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment

2022 · Nicholas Jones, Brian Ngo, et al. · Cancer Research · 1

Abstract 2793: Minimal residual disease (MRD) as a predictive biomarker/endpoint for novel drug development

2022 · Nicholas Jones, Brian Ngo, et al. · Cancer Research

Use of Receptor Occupancy Assays on Cells from Peripheral Blood As a Model to Determine Therapeutic Efficacy

2021 · Nicholas Jones, Floyd Davis, et al. · Blood

Validation of a Sensitive Flow Cytometry Assay to Assess Minimal Residual Disease of Multiple Myeloma Cells in Apheresis Product

2018 · Nicholas Jones, Josette William Ragheb, et al. · Blood

Works count: 11

Citation count: 154

H-index: 5

I10-index: 4